News & Announcements

February 2019
CAMBRIDGE, Mass. — Today, Kelly Blanchard, President of Ibis Reproductive Health, released the statement below about the current administration’s sweeping changes to Title X. “On Friday, the Trump administration continued its attacks on people’s—and especially women...
February 2019
A new Texas Policy Evaluation Project (TxPEP) study shows that use of medication abortion, also known as “the abortion pill,” bounced back in Texas after a March 2016 label change by the US Food and Drug Administration (FDA). The label change impacted the use of mifepristone, one of the...
January 2019
CAMBRIDGE, Mass. — Today, Kelly Blanchard, President of Ibis Reproductive Health, released the statement below about New York’s new law to protect and expand reproductive health and rights, throughout pregnancy. “ New York state law now permits abortions to be ‘performed by...
January 2019
CAMBRIDGE, Mass. — Today, Kelly Blanchard, President of Ibis Reproductive Health, released the statement below about the anniversary of the Roe v. Wade decision. “Forty-six years after the Supreme Court recognized that laws prohibiting abortion violated a woman’s constitutional...
November 2018
Over the last 16 years, research from Ibis Reproductive Health has informed policy and practice change and paved the way for innovation in service delivery for abortion and other sexual and reproductive health care. We're proud of our accomplishments (view our "16 highlights from Ibis Reproductive...
October 2018
CAMBRIDGE, Mass. — Today, Kelly Blanchard, President, released the statement below in response to the Senate’s confirmation of Justice Brett Kavanaugh to the Supreme Court of the United States. “Like many others across the country, I watched Justice Kavanaugh’s confirmation...